Connect with us

Government

Wider War Will Bring Inevitable Attempts At Martial Law In America

Wider War Will Bring Inevitable Attempts At Martial Law In America

Authored by Brandon Smith via Alt-Market.us,

Not long ago at the height…

Published

on

Wider War Will Bring Inevitable Attempts At Martial Law In America
Authored by Brandon Smith via Alt-Market.us, Not long ago at the height of fear over the global pandemic the US underwent a change that many people argued would never happen. For years I have heard people say that authoritarian controls in America are “tinfoil hat conspiracy theory” and doom mongering – All the prepping, all the talk of community organizing, all the guns and the gear and the training were for nothing. Then…the covid agenda hit like a freight train. Our constitutional rights were no longer set in stone, but mere guidelines that government officials could bend or break in the name of “public health safety.” Laws no longer had to be passed through a series of checks and balances; mandates could be implemented as if they were laws without public oversight and enforced unilaterally. There was talk (primarily among Democrats) of severe punishments for people who refused the pointless covid vaccines. They wanted vaccine passports, they wanted prison time for those that spoke publicly against the vax, they wanted people’s jobs taken away, they wanted their children taken away, and there were even plans to build covid detention centers to segregate and lock up “vax deniers.” It boggles the mind, but this was serious debate within the US and it was all triggered in the span of a year. Nearly half the country was willing to abandon the Bill of Rights over a virus with a survival rate of 99.8%. The conspiracy theorists were right all along; our freedoms rest on a razor’s edge and preparing to survive and fight for those freedoms is perfectly rational. Luckily, the covid agenda failed. The mandates were ultimately blocked by red states and in many rural areas they were barely enforced at all. Biden’s vaccine passport attempt was stopped cold by the Supreme Court, but I have long believed that the Supreme Court made this decision exactly because of the level of public resistance.  They knew if they pressed the issue, civil war was on the table. Medical authoritarianism collapsed because conservatives and independents were not onboard and they could not be shamed into compliance. But what happens when there is a crisis that DOES scare conservatives? What happens when the political right perceives a true threat? Does freedom then become untenable? Viruses frighten progressives (most things frighten progressives), but what frightens conservatives? Well, it’s not a hard fast rule, but generally speaking conservatives are most disturbed by the threat of invasion. Ask any conservative if they were worried about covid or worried about the crisis on the southern border during the pandemic and the vast majority of them would say the border without hesitation. Conservatives fear cultural infiltration and co-option, they fear the steady and deliberate whittling away of their American heritage and by extension their freedoms by alien impostors. And, they fear the certain blitzkrieg of the US by organized terrorism should the borders remain open. The question is, are they willing to assuage their fears by sacrificing the very freedoms they want to protect? In 2001 after 9/11, the conservative movement was a much different animal than it is today. This was pre-Ron Paul and pre-Libertarian influence. The Neo-cons ruled the roost and had far reaching power over public perception, making the push for the dismissal of constitutional rights unprecedented. The Patriot Act mentality was widespread and the thirst for war was palpable. I have seen conservatives stray from the Bill of Rights in the past in the name of fighting against a possible invasion.  I remember this vividly. Today, the elements in play are not the same as 2001. Anyone who argues otherwise was likely a child during the 9/11 era or has a skewed understanding of the changes that have taken place among conservatives since those days. The Ron Paul movement changed a lot for the better, but primarily within the conservative constituency. Regular people changed their thinking on what it means to trade liberty for security. The GOP? It’s a pipe dream to think we could ever completely change the GOP.  At least covid proved we have allies at the state and local level The real problem is in the old guard of Neo-cons still influencing the path of the Republican Party. These are people who happily ally with Democrats behind the scenes, they have close ties to establishment elites and their loyalty rests in the hands of globalists. If the globalists want war, then the Neo-cons want war and they will do anything to get it, including create it. That’s how it works. And this time around I think they’re going to get what they want. The Ukraine event failed to lure Americans into supporting direct intervention (a majority of Americans don’t even support funding for Ukraine), but Israel is another matter. There are very old and tribal implications than pull on the souls of conservatives when it comes to the conflicts in the Middle East. There are religious factors, yes, but I suspect this is overblown by critics who think evangelicals are running the show. This is not reality. The Christian mandate has nowhere near the same influence it did back in 2001. In fact, churches have become so weak that they are now being overtaken by LGBT infiltration and trans activism. This never would have been tolerated 20 years ago – They would have tarred and feathered such activists back then. If this sort of thing is being allowed to happen right in our backyards today then you can be damn sure that religion is not the driving force for war overseas. No, when it comes to Israel and the implications of war the concern is once again rooted in cultural erasure. To be fair, it’s not a paranoid delusion.  Western culture is in fact being systematically dismantled and mass immigration is a part of that agenda. It’s also true that Islamic ideology is completely incompatible with western beliefs including the concept of individualism. Muslim systems are authoritarian in nature, that is what Sharia Law is. So, when conservatives see the potential for the fall of Israel they associate this with the fall of the west, and they will seek to stop it if they can. Beyond Israel is the concern that an invasion of Muslim extremists is already well underway in the US with open border policies becoming the norm under Joe Biden. And here is where the trap is set… Martial law in the US would only ever work if a majority of conservatives support it. This is a fact. Without our backing martial law will fail, just as the covid mandates failed. Keep in mind, Biden and his globalist friends have used every possible tactic to make martial law an inevitability. Economic instability and stagflation have created a spike in violent crime and looting. Mass illegal migration is dragging down state welfare systems and is creating a trend of cultural dilution. Open borders have allowed any number of possible foreign hostiles into the US. In the midst of war the government desire to control information and public discourse will be at its apex.  However, as we have seen during covid and the Ukraine war, they have not proven effective at accomplishing this.  As long as the internet is in place it does not matter what kind of algorithms Big Tech applies to stifle the truth, the truth still finds a way.  This means that the establishment will have to pursue extreme measures that could only be achieved within a martial law environment.  I see this situation going one of two ways if the current geopolitical trend continues…

Option A:

A multi-front war breaks out in the Middle East including nations like Iran, Syria, Lebanon, Jordan and Yemen. Israel faces serious failure. The US is dragged into the war, or, Israel uses its nuclear arsenal to destroy the resources (including populations) of enemy nations, leading to the possible involvement of China and Russia, and thus, the US is still dragged in. Riots and terror attacks become a regular occurrence in the US, not just initiated by Muslim extremist infiltrators but also leftists who have attached themselves to the cause. A draft is initiated which conservatives support in the hopes that it will help dissolve the riots. The draft will sink millions of weak, soft zennials (including women) into a bloody quagmire that they have no capacity to adapt to.  Draft protests and riots become the norm, pushing conservatives to support even stricter enforcement. Finally, martial law is announced, but the soldiers used on American soil to “protect us” from riots and terrorists will be primarily foreign nationals – Illegal migrants given an easy shot at citizenry if they join the military and put the boot down on dissenters, which they will gladly do because they have no cultural attachment to America or Americans. At this stage the constitution will essentially die.

Option B:

The war expands and Israel faces imminent destruction. Biden commits US naval forces to the fight along with ground troops, primarily Special Forces. He then calls for full deployment of US ground forces to the region, but in this scenario the majority of conservatives do not support the action, just as they did not support deployment to Ukraine. Biden tries to implement a draft in order to force the momentum. Conservatives refuse to comply or allow their children to be sent to die in a foreign conflict. On this one issue, conservatives and leftists actually agree, even if it is for completely different reasons. The country is then hit with an endless series of terror attacks, each one presented as a reason why the public must back the war. Each attack is cheered by the leftist activists as an act of “decolonization.” Conservatives see this ploy for what it is and still refuse to support the war, taking an “America First” position. Why fight overseas when it’s America that’s under duress? Biden still attempts martial law. He offers automatic citizenship to illegal immigrants if they serve in the military and uses some of these troops as an occupation presence at home. Leftists don’t want to fight in the Middle East, but they do like to see migrants given easy citizenship and power. They defend the measure – They figure if the migrants fill the ranks of the military maybe they won’t be drafted. Conservatives rebel, America enters either balkanization or civil war, or both. Patriots are accused of helping the enemies of the United States and are also labeled terrorists. From this point on, anything could happen.
I believe the Israeli trigger may be bigger than covid in terms of the potential global disaster and global tyranny that could unfold. If it continues to escalate and turns into a multi-regional conflict the chances of the fight coming back to America are high. Not just in terms of terrorism, but also in terms of civil unrest and war on our doorstep. If we support the war, martial law is a certainty. If we don’t support the war, martial law will be attempted but at least there are scenarios where it could fail. I would argue that the only thing that will save America at this stage is the growth of the America First movement. When we talk about America First, this includes not just American security but also American freedoms. There is NO REASON why we can’t have both. If conservatives (and independents) get lured into WWIII, it will be the end. *  *  * If you would like to support the work that Alt-Market does while also receiving content on advanced tactics for defeating the globalist agenda, subscribe to our exclusive newsletter The Wild Bunch Dispatch.  Learn more about it HERE.
Tyler Durden Sun, 10/29/2023 - 07:00

Read More

Continue Reading

Government

Glimpse Of Sanity: Dartmouth Returns Standardized Testing For Admission After Failed Experiment

Glimpse Of Sanity: Dartmouth Returns Standardized Testing For Admission After Failed Experiment

In response to the virus pandemic and nationwide…

Published

on

Glimpse Of Sanity: Dartmouth Returns Standardized Testing For Admission After Failed Experiment

In response to the virus pandemic and nationwide Black Lives Matter riots in the summer of 2020, some elite colleges and universities shredded testing requirements for admission. Several years later, the test-optional admission has yet to produce the promising results for racial and class-based equity that many woke academic institutions wished.

The failure of test-optional admission policies has forced Dartmouth College to reinstate standardized test scores for admission starting next year. This should never have been eliminated, as merit will always prevail. 

"Nearly four years later, having studied the role of testing in our admissions process as well as its value as a predictor of student success at Dartmouth, we are removing the extended pause and reactivating the standardized testing requirement for undergraduate admission, effective with the Class of 2029," Dartmouth wrote in a press release Monday morning. 

"For Dartmouth, the evidence supporting our reactivation of a required testing policy is clear. Our bottom line is simple: we believe a standardized testing requirement will improve—not detract from—our ability to bring the most promising and diverse students to our campus," the elite college said. 

Who would've thought eliminating standardized tests for admission because a fringe minority said they were instruments of racism and a biased system was ever a good idea? 

Also, it doesn't take a rocket scientist to figure this out. More from Dartmouth, who commissioned the research: 

They also found that test scores represent an especially valuable tool to identify high-achieving applicants from low and middle-income backgrounds; who are first-generation college-bound; as well as students from urban and rural backgrounds.

All the colleges and universities that quickly adopted test-optional admissions in 2020 experienced a surge in applications. Perhaps the push for test-optional was under the guise of woke equality but was nothing more than protecting the bottom line for these institutions. 

A glimpse of sanity returns to woke schools: Admit qualified kids. Next up is corporate America and all tiers of the US government. 

Tyler Durden Mon, 02/05/2024 - 17:20

Read More

Continue Reading

International

Four burning questions about the future of the $16.5B Novo-Catalent deal

To build or to buy? That’s a classic question for pharma boardrooms, and Novo Nordisk is going with both.
Beyond spending billions of dollars to expand…

Published

on

To build or to buy? That’s a classic question for pharma boardrooms, and Novo Nordisk is going with both.

Beyond spending billions of dollars to expand its own production capacity for its weight loss drugs, the Danish drugmaker said Monday it will pay $11 billion to acquire three manufacturing plants from Catalent. It’s part of a broader $16.5 billion deal with Novo Holdings, the investment arm of the pharma’s parent group, which agreed to acquire the contract manufacturer and take it private.

It’s a big deal for all parties, with potential ripple effects across the biotech ecosystem. Here’s a look at some of the most pressing questions to watch after Monday’s announcement.

Why did Novo do this?

Novo Holdings isn’t the most obvious buyer for Catalent, particularly after last year’s on-and-off M&A interest from the serial acquirer Danaher. But the deal could benefit both Novo Holdings and Novo Nordisk.

Novo Nordisk’s biggest challenge has been simply making enough of the weight loss drug Wegovy and diabetes therapy Ozempic. On last week’s earnings call, Novo Nordisk CEO Lars Fruergaard Jørgensen said the company isn’t constrained by capital in its efforts to boost manufacturing. Rather, the main challenge is the limited amount of capabilities out there, he said.

“Most pharmaceutical companies in the world would be shopping among the same manufacturers,” he said. “There’s not an unlimited amount of machinery and people to build it.”

While Novo was already one of Catalent’s major customers, the manufacturer has been hamstrung by its own balance sheet. With roughly $5 billion in debt on its books, it’s had to juggle paying down debt with sufficiently investing in its facilities. That’s been particularly challenging in keeping pace with soaring demand for GLP-1 drugs.

Novo, on the other hand, has the balance sheet to funnel as much money as needed into the plants in Italy, Belgium, and Indiana. It’s also struggled to make enough of its popular GLP-1 drugs to meet their soaring demand, with documented shortages of both Ozempic and Wegovy.

The impact won’t be immediate. The parties expect the deal to close near the end of 2024. Novo Nordisk said it expects the three new sites to “gradually increase Novo Nordisk’s filling capacity from 2026 and onwards.”

As for the rest of Catalent — nearly 50 other sites employing thousands of workers — Novo Holdings will take control. The group previously acquired Altasciences in 2021 and Ritedose in 2022, so the Catalent deal builds on a core investing interest in biopharma services, Novo Holdings CEO Kasim Kutay told Endpoints News.

Kasim Kutay

When asked about possible site closures or layoffs, Kutay said the team hasn’t thought about that.

“That’s not our track record. Our track record is to invest in quality businesses and help them grow,” he said. “There’s always stuff to do with any asset you own, but we haven’t bought this company to do some of the stuff you’re talking about.”

What does it mean for Catalent’s customers? 

Until the deal closes, Catalent will operate as a standalone business. After it closes, Novo Nordisk said it will honor its customer obligations at the three sites, a spokesperson said. But they didn’t answer a question about what happens when those contracts expire.

The wrinkle is the long-term future of the three plants that Novo Nordisk is paying for. Those sites don’t exclusively pump out Wegovy, but that could be the logical long-term aim for the Danish drugmaker.

The ideal scenario is that pricing and timelines remain the same for customers, said Nicole Paulk, CEO of the gene therapy startup Siren Biotechnology.

Nicole Paulk

“The name of the group that you’re going to send your check to is now going to be Novo Holdings instead of Catalent, but otherwise everything remains the same,” Paulk told Endpoints. “That’s the best-case scenario.”

In a worst case, Paulk said she feared the new owners could wind up closing sites or laying off Catalent groups. That could create some uncertainty for customers looking for a long-term manufacturing partner.

Are shareholders and regulators happy? 

The pandemic was a wild ride for Catalent’s stock, with shares surging from about $40 to $140 and then crashing back to earth. The $63.50 share price for the takeover is a happy ending depending on the investor.

On that point, the investing giant Elliott Investment Management is satisfied. Marc Steinberg, a partner at Elliott, called the agreement “an outstanding outcome” that “clearly maximizes value for Catalent stockholders” in a statement.

Elliott helped kick off a strategic review last August that culminated in the sale agreement. Compared to Catalent’s stock price before that review started, the deal pays a nearly 40% premium.

Alessandro Maselli

But this is hardly a victory lap for CEO Alessandro Maselli, who took over in July 2022 when Catalent’s stock price was north of $100. Novo’s takeover is a tacit acknowledgment that Maselli could never fully right the ship, as operational problems plagued the company throughout 2023 while it was limited by its debt.

Additional regulatory filings in the next few weeks could give insight into just how competitive the sale process was. William Blair analysts said they don’t expect a competing bidder “given the organic investments already being pursued at other leading CDMOs and the breadth and scale of Catalent’s operations.”

The Blair analysts also noted the companies likely “expect to spend some time educating relevant government agencies” about the deal, given the lengthy closing timeline. Given Novo Nordisk’s ascent — it’s now one of Europe’s most valuable companies — paired with the limited number of large contract manufacturers, antitrust regulators could be interested in taking a close look.

Are Catalent’s problems finally a thing of the past?

Catalent ran into a mix of financial and operational problems over the past year that played no small part in attracting the interest of an activist like Elliott.

Now with a deal in place, how quickly can Novo rectify those problems? Some of the challenges were driven by the demands of being a publicly traded company, like failing to meet investors’ revenue expectations or even filing earnings reports on time.

But Catalent also struggled with its business at times, with a range of manufacturing delays, inspection reports and occasionally writing down acquisitions that didn’t pan out. Novo’s deep pockets will go a long way to a turnaround, but only the future will tell if all these issues are fixed.

Kutay said his team is excited by the opportunity and was satisfied with the due diligence it did on the company.

“We believe we’re buying a strong company with a good management team and good prospects,” Kutay said. “If that wasn’t the case, I don’t think we’d be here.”

Amber Tong and Reynald Castañeda contributed reporting.

Read More

Continue Reading

International

Petrina Kamya, Ph.D., Head of AI Platforms at Insilico Medicine, presents at BIO CEO & Investor Conference

Petrina Kamya, PhD, Head of AI Platforms and President of Insilico Medicine Canada, will present at the BIO CEO & Investor Conference happening Feb….

Published

on

Petrina Kamya, PhD, Head of AI Platforms and President of Insilico Medicine Canada, will present at the BIO CEO & Investor Conference happening Feb. 26-27 at the New York Marriott Marquis in New York City. Dr. Kamya will speak as part of the panel “AI within Biopharma: Separating Value from Hype,” on Feb. 27, 1pm ET along with Michael Nally, CEO of Generate: Biomedicines and Liz Schwarzbach, PhD, CBO of BigHat Biosciences.

Credit: Insilico Medicine

Petrina Kamya, PhD, Head of AI Platforms and President of Insilico Medicine Canada, will present at the BIO CEO & Investor Conference happening Feb. 26-27 at the New York Marriott Marquis in New York City. Dr. Kamya will speak as part of the panel “AI within Biopharma: Separating Value from Hype,” on Feb. 27, 1pm ET along with Michael Nally, CEO of Generate: Biomedicines and Liz Schwarzbach, PhD, CBO of BigHat Biosciences.

The session will look at how the latest artificial intelligence (AI) tools – including generative AI and large language models – are currently being used to advance the discovery and design of new drugs, and which technologies are still in development. 

The BIO CEO & Investor Conference brings together over 1,000 attendees and more than 700 companies across industry and institutional investment to discuss the future investment landscape of biotechnology. Sessions focus on topics such as therapeutic advancements, market outlook, and policy priorities.

Insilico Medicine is a leading, clinical stage AI-driven drug discovery company that has raised over $400m in investments since it was founded in 2014. Dr. Kamya leads the development of the Company’s end-to-end generative AI platform, Pharma.AI from Insilico’s AI R&D Center in Montreal. Using modern machine learning techniques in the context of chemistry and biology, the platform has driven the discovery and design of 30+ new therapies, with five in clinical stages – for cancer, fibrosis, inflammatory bowel disease (IBD), and COVID-19. The Company’s lead drug, for the chronic, rare lung condition idiopathic pulmonary fibrosis, is the first AI-designed drug for an AI-discovered target to reach Phase II clinical trials with patients. Nine of the top 20 pharmaceutical companies have used Insilico’s AI platform to advance their programs, and the Company has a number of major strategic licensing deals around its AI-designed therapeutic assets, including with Sanofi, Exelixis and Menarini. 

 

About Insilico Medicine

Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. www.insilico.com 


Read More

Continue Reading

Trending